Industry Voices and Cannabis News | Page 10 of 135 | Cannabiz

‘Strong results’: Trial finds high-dose CBD reduced neuropathic pain

by Adam Sheldon June 2, 2026June 8, 2026

High-dose CBD reduced chronic neuropathic pain in a placebo-controlled clinical trial conducted by researchers from the […]

LGP-Cannatrek set to play ‘active role’ in global industry consolidation

by Steve Jones June 1, 2026June 2, 2026

A ‘real get’ for the industry: MCCA appoints inaugural CEO

by Steve Jones June 1, 2026June 2, 2026

Nexalis suspends trial projects after funding partner withdraws support

by Steve Jones June 1, 2026June 1, 2026

Details emerge of Easykind legal stoush as former CEO rejects ‘false’ allegations of secret Phytoca deal

by Steve Jones May 28, 2026May 30, 2026

Mood State Medical secures ARTG inclusion for vaporiser

by Adam Sheldon May 27, 2026May 28, 2026

Hemp leaders tell inquiry cannabis regulation overlap is stifling growth

by Adam Sheldon May 27, 2026May 27, 2026

News in brief: Cannaponics raise tops $2.5m; Avecho receives $1.98m R&D incentive; Elixinol backs capital raising plans

by Adam Sheldon May 27, 2026June 8, 2026

Evidence still viewed as a ‘nice to have’ as key pain research paper delayed

by Adam Sheldon May 26, 2026May 28, 2026

Court clears LGP-Cannatrek merger ahead of June implementation

by Adam Sheldon May 26, 2026May 27, 2026